pubmed-article:20049950 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:20049950 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
pubmed-article:20049950 | lifeskim:mentions | umls-concept:C0009324 | lld:lifeskim |
pubmed-article:20049950 | lifeskim:mentions | umls-concept:C0034656 | lld:lifeskim |
pubmed-article:20049950 | lifeskim:mentions | umls-concept:C0127615 | lld:lifeskim |
pubmed-article:20049950 | lifeskim:mentions | umls-concept:C0439851 | lld:lifeskim |
pubmed-article:20049950 | lifeskim:mentions | umls-concept:C1707455 | lld:lifeskim |
pubmed-article:20049950 | lifeskim:mentions | umls-concept:C0035052 | lld:lifeskim |
pubmed-article:20049950 | lifeskim:mentions | umls-concept:C2603343 | lld:lifeskim |
pubmed-article:20049950 | lifeskim:mentions | umls-concept:C0524527 | lld:lifeskim |
pubmed-article:20049950 | lifeskim:mentions | umls-concept:C1552596 | lld:lifeskim |
pubmed-article:20049950 | lifeskim:mentions | umls-concept:C1947931 | lld:lifeskim |
pubmed-article:20049950 | pubmed:issue | 9 | lld:pubmed |
pubmed-article:20049950 | pubmed:dateCreated | 2010-8-30 | lld:pubmed |
pubmed-article:20049950 | pubmed:abstractText | Mesalamine is the first-line drug for the treatment of ulcerative colitis (UC). We directly compared the efficacy and safety of two mesalamine formulations for the induction of remission in patients with UC. | lld:pubmed |
pubmed-article:20049950 | pubmed:language | eng | lld:pubmed |
pubmed-article:20049950 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:20049950 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:20049950 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:20049950 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:20049950 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:20049950 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:20049950 | pubmed:month | Sep | lld:pubmed |
pubmed-article:20049950 | pubmed:issn | 1536-4844 | lld:pubmed |
pubmed-article:20049950 | pubmed:author | pubmed-author:ItoHiroakiH | lld:pubmed |
pubmed-article:20049950 | pubmed:author | pubmed-author:MatsumotoTaka... | lld:pubmed |
pubmed-article:20049950 | pubmed:author | pubmed-author:IidaMitsuoM | lld:pubmed |
pubmed-article:20049950 | pubmed:author | pubmed-author:SuzukiYasuoY | lld:pubmed |
pubmed-article:20049950 | pubmed:author | pubmed-author:HibiToshifumi... | lld:pubmed |
pubmed-article:20049950 | pubmed:author | pubmed-author:SasakiHidetak... | lld:pubmed |
pubmed-article:20049950 | pubmed:author | pubmed-author:TakanoYuichiY | lld:pubmed |
pubmed-article:20049950 | pubmed:author | pubmed-author:YoshidaToyomi... | lld:pubmed |
pubmed-article:20049950 | pubmed:issnType | Electronic | lld:pubmed |
pubmed-article:20049950 | pubmed:volume | 16 | lld:pubmed |
pubmed-article:20049950 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:20049950 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:20049950 | pubmed:pagination | 1567-74 | lld:pubmed |
pubmed-article:20049950 | pubmed:meshHeading | pubmed-meshheading:20049950... | lld:pubmed |
pubmed-article:20049950 | pubmed:meshHeading | pubmed-meshheading:20049950... | lld:pubmed |
pubmed-article:20049950 | pubmed:meshHeading | pubmed-meshheading:20049950... | lld:pubmed |
pubmed-article:20049950 | pubmed:meshHeading | pubmed-meshheading:20049950... | lld:pubmed |
pubmed-article:20049950 | pubmed:meshHeading | pubmed-meshheading:20049950... | lld:pubmed |
pubmed-article:20049950 | pubmed:meshHeading | pubmed-meshheading:20049950... | lld:pubmed |
pubmed-article:20049950 | pubmed:meshHeading | pubmed-meshheading:20049950... | lld:pubmed |
pubmed-article:20049950 | pubmed:meshHeading | pubmed-meshheading:20049950... | lld:pubmed |
pubmed-article:20049950 | pubmed:meshHeading | pubmed-meshheading:20049950... | lld:pubmed |
pubmed-article:20049950 | pubmed:meshHeading | pubmed-meshheading:20049950... | lld:pubmed |
pubmed-article:20049950 | pubmed:meshHeading | pubmed-meshheading:20049950... | lld:pubmed |
pubmed-article:20049950 | pubmed:meshHeading | pubmed-meshheading:20049950... | lld:pubmed |
pubmed-article:20049950 | pubmed:meshHeading | pubmed-meshheading:20049950... | lld:pubmed |
pubmed-article:20049950 | pubmed:meshHeading | pubmed-meshheading:20049950... | lld:pubmed |
pubmed-article:20049950 | pubmed:meshHeading | pubmed-meshheading:20049950... | lld:pubmed |
pubmed-article:20049950 | pubmed:meshHeading | pubmed-meshheading:20049950... | lld:pubmed |
pubmed-article:20049950 | pubmed:meshHeading | pubmed-meshheading:20049950... | lld:pubmed |
pubmed-article:20049950 | pubmed:meshHeading | pubmed-meshheading:20049950... | lld:pubmed |
pubmed-article:20049950 | pubmed:meshHeading | pubmed-meshheading:20049950... | lld:pubmed |
pubmed-article:20049950 | pubmed:meshHeading | pubmed-meshheading:20049950... | lld:pubmed |
pubmed-article:20049950 | pubmed:meshHeading | pubmed-meshheading:20049950... | lld:pubmed |
pubmed-article:20049950 | pubmed:year | 2010 | lld:pubmed |
pubmed-article:20049950 | pubmed:articleTitle | Direct comparison of two different mesalamine formulations for the induction of remission in patients with ulcerative colitis: a double-blind, randomized study. | lld:pubmed |
pubmed-article:20049950 | pubmed:affiliation | Digestive Disease Center of Excellence, Kitano Hospital, The Tazuke Kofukai Medical Research Institute, Osaka, Japan. | lld:pubmed |
pubmed-article:20049950 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:20049950 | pubmed:publicationType | Comparative Study | lld:pubmed |
pubmed-article:20049950 | pubmed:publicationType | Randomized Controlled Trial | lld:pubmed |
pubmed-article:20049950 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
pubmed-article:20049950 | pubmed:publicationType | Multicenter Study | lld:pubmed |